Nabriva Therapeutics plc Operating Expenses
Nabriva Therapeutics plc reported Operating Expenses of $21.50 million for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-08-08
- Nabriva Therapeutics plc operating expenses for the quarter ending 2019-06-30 was $21.50M, a 15.88% increase year-over-year.
- Nabriva Therapeutics plc operating expenses for the quarter ending 2019-03-31 was $20.95M, a 2.61% increase year-over-year.
- Nabriva Therapeutics plc operating expenses for the quarter ending 2018-12-31 was $31.68M, a 35.35% increase year-over-year.
- Nabriva Therapeutics plc operating expenses for the quarter ending 2018-09-30 was $53.39M, a 140.55% increase year-over-year.
- Nabriva Therapeutics plc operating expenses for fiscal 2018 was $124.03M, a 56.83% increase from fiscal 2017.
- Nabriva Therapeutics plc operating expenses for fiscal 2017 was $79.09M, a 28.54% increase from fiscal 2016.
- Nabriva Therapeutics plc operating expenses for fiscal 2016 was $61.53M, a 95.18% increase from fiscal 2015.
- Nabriva Therapeutics plc operating expenses for fiscal 2015 was $31.52M, a 140.76% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2019-06-30 | $21.50M 10-Q · filed 2019-08-08 | $42.45M 10-Q · filed 2019-08-08 | $74.12M derived: sum of 3 quarters · filed 2019-08-08 | $127.51M derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | $20.95M 10-Q · filed 2019-05-10 | $52.62M derived: sum of 2 quarters · filed 2019-05-10 | $106.01M derived: sum of 3 quarters · filed 2019-05-10 | $124.56M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-12-31 | $31.68M 10-K · filed 2019-03-12 | $85.06M derived: sum of 2 quarters · filed 2019-03-12 | $103.62M derived: sum of 3 quarters · filed 2019-08-08 | $124.03M 10-K · filed 2019-03-12 |
| 2018-09-30 | $53.39M 10-K · filed 2019-03-12 | $71.94M derived: sum of 2 quarters · filed 2019-08-08 | $92.36M 10-Q · filed 2018-11-06 | $115.76M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $18.55M 10-Q · filed 2019-08-08 | $38.97M 10-Q · filed 2019-08-08 | $62.37M derived: sum of 3 quarters · filed 2019-08-08 | $84.56M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $20.41M 10-Q · filed 2019-05-10 | $43.82M derived: sum of 2 quarters · filed 2019-05-10 | $66.01M derived: sum of 3 quarters · filed 2019-05-10 | $82.62M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $23.40M 10-K · filed 2019-03-12 | $45.60M derived: sum of 2 quarters · filed 2019-03-12 | $62.21M derived: sum of 3 quarters · filed 2019-03-12 | $79.09M 10-K · filed 2019-03-12 |
| 2017-09-30 | $22.19M 10-K · filed 2019-03-12 | $38.81M derived: sum of 2 quarters · filed 2019-03-12 | $55.68M 10-Q · filed 2018-11-06 | $72.73M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $16.61M 10-K · filed 2019-03-12 | $33.49M 10-Q · filed 2018-08-09 | $50.54M derived: sum of 3 quarters · filed 2019-03-12 | $65.59M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $16.88M 10-K · filed 2019-03-12 | $33.92M derived: sum of 2 quarters · filed 2019-03-12 | $48.98M derived: sum of 3 quarters · filed 2019-03-12 | $62.29M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $17.05M 10-K · filed 2018-03-16 | $32.10M derived: sum of 2 quarters · filed 2018-03-16 | $45.41M derived: sum of 3 quarters · filed 2018-03-16 | $61.53M 10-K · filed 2019-03-12 |
| 2016-09-30 | $15.05M 10-K · filed 2018-03-16 | $28.36M derived: sum of 2 quarters · filed 2018-03-16 | $44.48M 10-Q · filed 2017-11-09 | $55.70M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | $13.31M 10-K · filed 2018-03-16 | $29.43M 10-Q · filed 2017-08-07 | $40.65M derived: sum of 3 quarters · filed 2018-03-16 | $50.27M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | $16.12M 10-K · filed 2018-03-16 | $27.34M derived: sum of 2 quarters · filed 2018-03-16 | $36.96M derived: sum of 3 quarters · filed 2018-03-16 | $43.38M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $11.21M 10-K · filed 2017-03-24 | $20.84M derived: sum of 2 quarters · filed 2017-03-24 | $27.26M derived: sum of 3 quarters · filed 2017-03-24 | $31.52M 10-K · filed 2018-03-16 |
| 2015-09-30 | $9.62M 10-K · filed 2017-03-24 | $16.04M derived: sum of 2 quarters · filed 2017-03-24 | $20.31M derived: sum of 3 quarters · filed 2017-03-24 | |
| 2015-06-30 | $6.42M 10-K · filed 2017-03-24 | $10.69M derived: sum of 2 quarters · filed 2017-03-24 | ||
| 2015-03-31 | $4.27M 10-K · filed 2017-03-24 | |||
| 2014-12-31 | $13.09M 10-K · filed 2017-03-24 |